Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Tuberculosis & Lung Cancer News Monitoring

Get by Email • RSS

Published on May 1, 2025

Association and Predictive Ability between Inflammatory Burden Index and Fever Following Endobronchial Forceps Biopsy in ...

Introduction Endobronchial biopsy (EBB) is a crucial diagnostic method for lung cancer.1 Various biopsy techniques are used in EBB, including forceps biopsies, cryobiopsies, bronchial brushing, and needle aspiration biopsies, with forceps biopsy being the …

Source: Dove Medical Press - Neutral
Published on 08:42 GMT

Comprehensive Analysis of Pathogen Diversity and Diagnostic Biomarkers in Patients with Suspected Pulmonary Tuberculosis ...

Introduction Tuberculosis (TB), caused by the Mycobacterium tuberculosis (MTB) complex, remains a significant global public health challenge and contributes to high morbidity and mortality rates worldwide.1 Historically, TB has been one of the deadliest …

Source: Dove Medical Press - Neutral
Published on 07:19 GMT

FDA Approves Upadacitinib for Giant Cell Arteritis in Adults

The FDA has approved upadacitinib, a Janus kinase inhibitor, for the treatment of giant cell arteritis in adults-marking the first new approval for the condition since tocilizumab in 2017, according to a press release. The approvals are supported by …

Source: Medical Dialogues - Indeterminate
Published on May 1, 2025

Setting Goals: How to Navigate a Chronic Inflammatory Disease

(BPT) - Content sponsored and provided by Pfizer. Ashley partnered with Pfizer to share her experience living with moderate to severe rheumatoid arthritis (RA). Growing up, Ashley was active, played sports, and exercised regularly. So, when she began …

Source: South Dade News Leader - Florida - Pending
Published on May 1, 2025

T Cell Aging: An Important Target for Perioperative Immunomodulation

Invasive perioperative procedures often trigger an inflammatory response in patients, stimulating immune regulatory mechanisms in their bodies. Patients’ immune function gradually declines as they age due to the degeneration of immune organs, chronic …

Source: Dove Medical Press - Neutral
Published on May 1, 2025

How did smoking on flights end up getting banned despite its glamorous role in aviation?

When you think about unruly passengers, the first things that probably come to mind are drunken brawls, passengers trying to open aircraft doors, and flight attendants receiving physical and verbal abuse. Whether you’ve traveled with them or simply read …

Source: AeroTime News - Neutral
Published on Apr 30, 2025

Cancer Vaccines Begin to Take Center Stage With Investigators Anticipating an Even Brighter Future

Vaccines are a major topic of interest in the world of cancer care, offering the promise of an effective treatment option in traditionally hard-to-manage tumor types that can potentially be personalized for individual patients. In order to further …

Source: OncLive - Pending
Published on Apr 30, 2025

AbbVie receives US FDA approval for Rinvoq for treatment of adults with giant cell arteritis

AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the European Commission recently granted marketing authorization …

Source: Pharmabiz.com - Neutral
Published on Apr 29, 2025

RINVOQ® Receives U.S. FDA Approval for Giant Cell Arteritis

RINVOQ (upadacitinib) is now the first and only oral Janus Kinase (JAK) inhibitor approved for the treatment of GCA in adults Also known as temporal arteritis, GCA is the most common vasculitis affecting adults in Western countries 2 This marks the ninth …

Source: Investing News Network - Neutral
Published on Apr 28, 2025

Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic target identification capability. CAMBRIDGE, UNITED KINGDOM, April 28, 2025 /⁨EINPresswire.com⁩/ -- Intellomx (Intelligent …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on Apr 26, 2025

Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy

Introduction Immunotherapy represents a transformative approach to treating malignant tumors, leveraging both the innate and adaptive immune systems to recognize and eliminate cancer cells.1 Among various immune pathways, the cyclic GMP-AMP synthase- …

Source: Dove Medical Press - Neutral

03 days 17:33:11

Featured Releases

Got News to Share? · Submit · See All

Published on May 1, 2025 - 09:45 GMT

Louisiana Mesothelioma Victims Center Urges the Family of a Journeyman Plumber Who Now Has Mesothelioma or Lung Cancer ...

NEW ORLEANS, LA, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- The Louisiana Mesothelioma Victims Center says, "We are urging the family of a former journeyman plumber who has just been diagnosed with mesothelioma or lung cancer in …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on April 28, 2025 - 11:00 GMT

AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening

LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, and EmeritusDX, a rapidly growing cancer …

Distribution channels: Companies, Technology ...

Published on May 1, 2025 - 22:18 GMT

Empowering fellows with advanced interventional pulmonology skills

Dr. Bianka Eperjesiova, North Florida/South Georgia Veterans Health System (NF/SGVHS) director of Interventional Pulmonology (IP), and her dedicated team are making significant strides in the field of interventional pulmonology by educating fellows …

Distribution channels:
Published on May 1, 2025 - 21:04 GMT

Coherus to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life Science Conference in New York, NY …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on April 27, 2025 - 16:05 GMT

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small ...

REDWOOD CITY, Calif., April 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced new clinical data for …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 20:05 GMT

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on May 1, 2025 - 13:30 GMT

Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early ...

TARRYTOWN, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its oncology and hematology portfolio will be shared at the 2025 American Society of Clinical Oncology (ASCO) Annual …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 10:00 GMT

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine phosphorylation- …

Distribution channels: Technology ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 808,805,814 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 10:03 GMT

Rosuvastatin Calcium Market CAGR 5.11 % with Growth USD 940.6 Billion by 2033

Rosuvastatin Calcium market size in 2025 is estimated to be 631.33 million, with projections to grow to 940.6 million by 2033 at a CAGR of 5.11%. PUNE, MAHARASHTRA, INDIA, May 2, 2025 /⁨EINPresswire.com⁩/ -- "Rosuvastatin Calcium Market" …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:05 GMT

Celebrating One Year of 5-Star Urgent Care Services in Clear Lake, Houston

HOUSTON, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Priority Urgent Care and Walk-In Clinic - Clear Lake proudly celebrates its one-year anniversary of delivering exceptional, patient-centered urgent care services in Clear Lake, with a …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on May 2, 2025 - 07:47 GMT

PowerDMARC is an Official Sponsor of MSPGeekCon 2025 in Orlando

ORLANDO, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- PowerDMARC, a global leader in email authentication and DMARC management solutions, is excited to announce its sponsorship and participation at MSPGeekCon 2025, taking place May 4–6 at …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:39 GMT

Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI

Emerging trends in AI-based skin assessment, rising preference for plant-based solutions, and expansion of medical-grade skincare to drive 9.0% CAGR growth NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global hyperpigmentation …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:23 GMT

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The hidradenitis suppurativa …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:14 GMT

Drowning is the leading cause of death children ages 1-4

Drowning is a serious issue, how to become safer in, on, or near the water. NEW YORK, NY, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Drowning is the leading cause of death for children ages 1-4 May is National Water Safety Awareness …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 2, 2025 - 05:13 GMT

Qualiphy Simplifies Good Faith Exams for Medical Spas and Clinics

BEVERLY HILLS, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- In response to growing demand for compliant, accessible healthcare solutions, Qualiphy has launched a turnkey telehealth infrastructure for aesthetic clinics, medical spas, and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:04 GMT

WeaponUP Now Accepts HSA/FSA Payments Through Flex

MIAMI, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- WeaponUP, the digital sword-yoga fusion platform, is proud to announce its new partnership with Flex, enabling customers to use their Health Savings Account (HSA) or Flexible Spending …

Distribution channels: Business & Economy, Gifts, Games & Hobbies ...
Published on May 2, 2025 - 04:34 GMT

Health City Robotic Surgery Transforms the Lives of Fibroid Patients

CAYMAN ISLANDS, May 1, 2025 /⁨EINPresswire.com⁩/ -- After more than a decade of living with pain and complications from uterine fibroids, a Caribbean woman has found relief through robotic-assisted surgery at Health City Cayman Islands. Ayanna, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 22:03 GMT

Tiller-Hewitt Launches New Growth Solutions for Healthcare Systems

Expanded suite addresses physician alignment, strategic growth, and network optimization amid industry-wide transformation. ST. LOUIS, MO, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- As healthcare organizations continue to face workforce …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 21:30 GMT

Venture Medical Announces Strategic Partnership with Plasmacure to Bring Cold Plasma Therapy System to the U.S. Market

Proven cold plasma therapy system for chronic wound treatment represents patient-first innovation. MISSOULA, MT, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Venture Medical, LLC, a leading provider of advanced wound care solutions, is proud …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 09:17 GMT

Best Anti-Snoring Devices: Stop Snoring Immediately. New Report Reveals Which Devices Actually Work.

New York, May 02, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted resource for product research and rankings, has officially released its list of the best anti-snoring devices, spotlighting three standout products designed to help individuals reduce snoring …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Maziar Mike Doustdar Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Ari Lehtoranta

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Ari Lehtoranta Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Eija Ronkainen

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Eija Ronkainen

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Eija Ronkainen Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...